MindRank Begins IND-enabling Studies of its first AI-designe

MindRank Begins IND-enabling Studies of its first AI-designed Drug, 8 Months After Program Initiation

/PRNewswire/ -- MindRank AI, an artificial intelligence (AI) driven biotech company, today announced that the company has nominated a preclinical candidate...

Related Keywords

China , Hangzhou , Zhejiang , Zhangming Niu , Months After Program Initiation , After Program , Mindrank Ai ,